This study tested the additive value of quantitative background parenchymal enhancement (BPE) assessed in the contralateral breast in the prediction of treatment response for patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy (NAC). BPE predictors were added to the prediction models together with functional tumor volume predictors. Our results showed that combined model achieved better prediction for pathologic complete response in HER2-positive HR-negative cancer subtype after 3 weeks of NAC. The additive values of BPE were also observed at inter-regimen (12-week) for triple negatives, and at the pre-surgery for HR-positive subtypes.
This abstract and the presentation materials are available to members only; a login is required.